Oxford Biodynamics PLC (OBD) - Total Assets
Based on the latest financial reports, Oxford Biodynamics PLC (OBD) holds total assets worth GBX9.09 Million GBX (≈ $1.11K USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Oxford Biodynamics PLC - Total Assets Trend (2013–2025)
This chart illustrates how Oxford Biodynamics PLC's total assets have evolved over time, based on quarterly financial data. Also see market cap of Oxford Biodynamics PLC for the company's overall valuation and market capitalisation.
Oxford Biodynamics PLC - Asset Composition Analysis
Current Asset Composition (September 2025)
Oxford Biodynamics PLC's total assets of GBX9.09 Million consist of 28.2% current assets and 71.8% non-current assets. Review OBD total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 17.2% |
| Accounts Receivable | GBX694.00K | 8.6% |
| Inventory | GBX195.00K | 2.4% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX1.11 Million | 13.7% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how Oxford Biodynamics PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Oxford Biodynamics PLC (OBD) share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Oxford Biodynamics PLC's current assets represent 28.2% of total assets in 2025, a decrease from 97.2% in 2013.
- Cash Position: Cash and equivalents constituted 17.2% of total assets in 2025, down from 83.9% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 0.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 13.7% of total assets.
Oxford Biodynamics PLC Competitors by Total Assets
Key competitors of Oxford Biodynamics PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Medpace Holdings Inc
NASDAQ:MEDP
|
USA | $2.06 Billion |
|
Chemclin Diagnostics Co. Ltd. A
SHG:688468
|
China | CN¥1.76 Billion |
|
Genetic Signatures Ltd
AU:GSS
|
Australia | AU$49.04 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
Oxford Biodynamics PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.01 | 2.59 | 7.77 |
| Quick Ratio | 1.89 | 2.48 | 7.46 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX1.91 Million | GBX4.08 Million | GBX8.36 Million |
Oxford Biodynamics PLC - Advanced Valuation Insights
This section examines the relationship between Oxford Biodynamics PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.58 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -33.2% |
| Total Assets | GBX8.09 Million |
| Market Capitalization | $60.04K USD |
Valuation Analysis
Below Book Valuation: The market values Oxford Biodynamics PLC's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Oxford Biodynamics PLC's assets decreased by 33.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Oxford Biodynamics PLC (2013–2025)
The table below shows the annual total assets of Oxford Biodynamics PLC from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | GBX8.09 Million ≈ $983.83 |
-33.22% |
| 2024-09-30 | GBX12.11 Million ≈ $1.47K |
-24.92% |
| 2023-09-30 | GBX16.13 Million ≈ $1.96K |
+42.16% |
| 2022-09-30 | GBX11.34 Million ≈ $1.38K |
-26.24% |
| 2021-09-30 | GBX15.38 Million ≈ $1.87K |
+0.17% |
| 2020-09-30 | GBX15.35 Million ≈ $1.87K |
-18.30% |
| 2019-09-30 | GBX18.79 Million ≈ $2.29K |
-10.26% |
| 2018-09-30 | GBX20.94 Million ≈ $2.55K |
+65.16% |
| 2017-09-30 | GBX12.68 Million ≈ $1.54K |
+40.57% |
| 2016-09-30 | GBX9.02 Million ≈ $1.10K |
-7.39% |
| 2015-09-30 | GBX9.74 Million ≈ $1.19K |
+57.53% |
| 2014-09-30 | GBX6.18 Million ≈ $752.29 |
+71.85% |
| 2013-09-30 | GBX3.60 Million ≈ $437.77 |
-- |
About Oxford Biodynamics PLC
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor i… Read more